Omnicell, Inc. (OMCL)
NASDAQ: OMCL · Real-Time Price · USD
44.41
+0.65 (1.49%)
At close: May 22, 2026, 4:00 PM EDT
44.44
+0.03 (0.07%)
After-hours: May 22, 2026, 6:11 PM EDT
Omnicell Revenue
Omnicell had revenue of $309.88M in the quarter ending March 31, 2026, with 14.91% growth. This brings the company's revenue in the last twelve months to $1.23B, up 7.86% year-over-year. In the year 2025, Omnicell had annual revenue of $1.18B with 6.53% growth.
Revenue (ttm)
$1.23B
Revenue Growth
+7.86%
P/S Ratio
1.65
Revenue / Employee
$347,534
Employees
3,525
Market Cap
2.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.18B | 72.61M | 6.53% |
| Dec 31, 2024 | 1.11B | -34.87M | -3.04% |
| Dec 31, 2023 | 1.15B | -148.84M | -11.49% |
| Dec 31, 2022 | 1.30B | 163.93M | 14.48% |
| Dec 31, 2021 | 1.13B | 239.81M | 26.88% |
| Dec 31, 2020 | 892.21M | -4.82M | -0.54% |
| Dec 31, 2019 | 897.03M | 109.72M | 13.94% |
| Dec 31, 2018 | 787.31M | 74.60M | 10.47% |
| Dec 31, 2017 | 712.71M | 16.81M | 2.41% |
| Dec 31, 2016 | 695.91M | 211.35M | 43.62% |
| Dec 31, 2015 | 484.56M | 43.66M | 9.90% |
| Dec 31, 2014 | 440.90M | 60.32M | 15.85% |
| Dec 31, 2013 | 380.59M | 66.56M | 21.19% |
| Dec 31, 2012 | 314.03M | 68.49M | 27.90% |
| Dec 31, 2011 | 245.54M | 23.13M | 10.40% |
| Dec 31, 2010 | 222.41M | 8.95M | 4.19% |
| Dec 31, 2009 | 213.46M | -38.41M | -15.25% |
| Dec 31, 2008 | 251.87M | 38.78M | 18.20% |
| Dec 31, 2007 | 213.08M | 58.37M | 37.73% |
| Dec 31, 2006 | 154.71M | 33.19M | 27.31% |
| Dec 31, 2005 | 121.52M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teladoc Health | 2.51B |
| Privia Health Group | 2.25B |
| Waystar Holding | 1.16B |
| GoodRx Holdings | 787.89M |
| Hinge Health | 646.34M |
| Doximity | 644.86M |
| 10x Genomics | 638.78M |
| Omada Health | 283.30M |
OMCL News
- 3 days ago - Omnicell announces removal of i.vSTATION syringe labels - TheFly
- 12 days ago - Omnicell Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 20 days ago - Omnicell to Present at the BofA Securities 2026 Healthcare Conference - Business Wire
- 25 days ago - Omnicell price target raised to $55 from $53 at Craig-Hallum - TheFly
- 25 days ago - Omnicell appoints Rick Couldry as SVP, chief pharmacy and clinical officer - TheFly
- 25 days ago - Omnicell Welcomes Hospital Pharmacy Leader Rick Couldry as Senior Vice President, Chief Pharmacy and Clinical Officer - Business Wire
- 26 days ago - Omnicell price target raised to $70 from $60 at KeyBanc - TheFly
- 26 days ago - Omnicell price target raised to $70 from $60 at KeyBanc - TheFly